Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now indicates that recruitment has ended for this study and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention label is updated to Intervention/Treatment and a new revision note (Revision: v3.6.0) appears, replacing the prior v3.5.5 note.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a new version was published as part of routine updates or QC. This does not alter the study content, eligibility, or results.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor change to the site’s current version display.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.